• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold

cafead

Administrator
Staff member
  • cafead   Dec 02, 2022 at 11:42: AM
via Four months after the FDA slapped a clinical hold on Beam Therapeutics’ phase 1 ready off-the-shelf CAR-T, the biotech is now free to proceed.

article source